-transparent.png){kind=logo}
Plasma tricyclic concentrations were assessed in 15 agoraphobic patients receiving combined imipramine and behavioral treatments. Imipramine but not N-desmethylimipramine plasma levels were found to significantly correlate with improvement. The results suggest that imipramine's effect in agoraphobia might be mediated predominantly through the serotonergic action of the parent drug. There was also suggestive evidence for differential antipanic and antiphobic-antidepressant effects. Implications for future studies of the mechanism of action of drug effects in agoraphobia are discussed.
Related Publications
M Mavissakalian, and
J M Perel, and
L Michelson
February 1967,
The British journal of psychiatry : the journal of mental science,
M Mavissakalian, and
J M Perel, and
L Michelson
July 1985,
Journal of affective disorders,
M Mavissakalian, and
J M Perel, and
L Michelson
November 1971,
Xenobiotica; the fate of foreign compounds in biological systems,
M Mavissakalian, and
J M Perel, and
L Michelson
July 1970,
Life sciences. Pt. 1: Physiology and pharmacology,
M Mavissakalian, and
J M Perel, and
L Michelson
January 1978,
Life sciences,
M Mavissakalian, and
J M Perel, and
L Michelson
January 1986,
Comprehensive psychiatry,
M Mavissakalian, and
J M Perel, and
L Michelson
October 1978,
Psychopharmacology bulletin,
M Mavissakalian, and
J M Perel, and
L Michelson
May 1974,
Zeitschrift fur klinische Chemie und klinische Biochemie,
M Mavissakalian, and
J M Perel, and
L Michelson
November 1982,
Pediatrics,
M Mavissakalian, and
J M Perel, and
L Michelson
June 1986,
Psychiatry research,
